Category: Clinical Trial
Clinical Trial market research reports by GlobalData
-
Oral Mucositis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Oral Mucositis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Oral Mucositis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spon ... Read More
-
Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Poin ... Read More
-
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Tr ... Read More
-
Clinical Trials - Where are we Headed with COVID-19 Trials?
Clinical Trials - Where are we Headed with COVID-19 Trials? Summary This report provides an overview of global COVID-19 clinical trials extracted from the GlobalData Pharma Intelligence Center on March 30, 2022. The purpose of this report is to provide insight into the overall clinical trial landsca ... Read More
-
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Co ... Read More
-
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape
Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Smoking Cessation therapeutics. Synopsis In 2022, Nearly 350 million people will q ... Read More
-
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Renal Cell Carcinomar therapeutics. Synopsis In 2022, there will be more than 1 ... Read More
-
Acute Myeloid Leukemia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Acute Myeloid Leukemia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Acute Myeloid Leukemia therapeutics. Synopsis In 2022, there wil ... Read More
-
Chronic Kidney Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Chronic Kidney Disease Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Chronic Kidney Disease (CKD) is a chronic condition in which patients suffer from an irreversible and progre ... Read More
-
Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, St ... Read More
-
Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type ... Read More
-
Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Endometriosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponso ... Read More
-
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial ... Read More
-
Osteoporosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Osteoporosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Osteoporosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor ... Read More
-
Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Dravet Syndrome therapeutics. Synopsis In 2022, there will be more than ... Read More
-
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Open-Angle Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, St ... Read More
-
Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor ... Read More
-
Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial P ... Read More
-
Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Alpha-1 Antitrypsin Deficiency Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Alpha-1 antitrypsin deficiency (AATD) is an inherited disease that causes an increased risk of chron ... Read More
-
Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Dysphagia Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Dysphagia therapeutics. Synopsis In 2022, there will be more than 182 million ... Read More
-
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Anxiety therapeutics. Synopsis In 2022, there will be more than 291 million pre ... Read More
-
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Alopecia areata therapeutics. Synopsis In 2022, there will be more than ... Read More
-
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Pancreatic Cancer therapeutics. Synopsis In 2022, there will be more ... Read More
-
Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Po ... Read More
Research Assistance
